|
Eris Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
21416.02 Cr.
|
P/BV
|
7.73
|
Book Value (Rs.)
|
203.46
|
|
52 Week High/Low (Rs.)
|
1910/1097
|
FV/ML
|
1/1
|
P/E(X)
|
60.87
|
|
Bookclosure
|
13/02/2025
|
EPS (Rs.)
|
25.83
|
Div Yield (%)
|
0.47
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2879.26 | 1991.30 | 1661.82 | 1326.17 | 1192.64 |
| Other Operating Revenues | 14.38 | 17.85 | 23.33 | 20.88 | 19.22 |
| Total Operating Revenues | 2893.64 | 2009.14 | 1685.15 | 1347.04 | 1211.86 |
| | | | | | |
| Other Income | 18.36 | 23.82 | 11.15 | 26.09 | 8.71 |
| Total Revenue | 2912.00 | 2032.96 | 1696.30 | 1373.14 | 1220.57 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 276.34 | 177.81 | 142.20 | 117.57 | 99.43 |
| Purchase Of Stock-In Trade | 473.12 | 201.52 | 206.33 | 141.72 | 177.01 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -35.47 | 0.72 | 3.82 | -0.78 | -38.17 |
| Employee Benefit Expenses | 505.09 | 403.82 | 346.16 | 252.25 | 229.30 |
| Finance Costs | 231.29 | 84.80 | 26.17 | 4.15 | 1.80 |
| Depreciation And Amortisation Expenses | 315.46 | 182.61 | 117.09 | 64.71 | 42.99 |
| Other Expenses | 657.36 | 550.45 | 449.90 | 351.32 | 313.72 |
| Total Expenses | 2423.19 | 1601.72 | 1291.66 | 930.94 | 826.07 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 488.81 | 431.24 | 404.64 | 442.20 | 394.50 |
| | | | | | |
| Profit/Loss Before Tax | 488.81 | 431.24 | 404.64 | 442.20 | 394.50 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 111.84 | 82.22 | 74.66 | 81.82 | 69.40 |
| Deferred Tax | 2.36 | -48.03 | -44.18 | -45.42 | -30.04 |
| Total Tax Expenses | 114.20 | 34.19 | 30.48 | 36.41 | 39.36 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 374.61 | 397.05 | 374.16 | 405.79 | 355.14 |
| | | | | | |
| Profit/Loss From Continuing Operations | 374.61 | 397.05 | 374.16 | 405.79 | 355.14 |
| | | | | | |
| Profit/Loss For The Period | 374.61 | 397.05 | 374.16 | 405.79 | 355.14 |
| | | | | | |
| Minority Interest | -22.83 | -5.07 | 8.00 | 0.32 | 0.00 |
| Share Of Profit/Loss Of Associates | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 351.84 | 391.98 | 382.16 | 406.11 | 355.14 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 25.85 | 28.82 | 28.10 | 29.89 | 26.16 |
| Diluted EPS (Rs.) | 25.81 | 28.79 | 28.07 | 29.88 | 26.14 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 100.06 | 0.00 | 99.94 | 81.65 | 74.68 |
